A correlative study of mixed fungal infection with special emphasis on mucormycosis in covid-19 patients: An early diagnosis improves the patient outcome

Registration ID: IJNRD_187795

Published ID: IJNRD2302249

DOI: Click Here to Get

Saba Shakil

Mucormycosis, Covid-19, Pandemic, Mixed infection, Cytology

Background: Mucormycosis is rare but fatal angioinvasive fungal infection which require prompt diagnosis and treatment.These are opportunistic organisms that affect people who are immunocompromised or on some steroids/chemotherapy drugs. Methods: The present study was conducted on 48 clinically suspected cases of rhino-orbital mucormycosis. Patients were between 30-70 years and presented with complaints of pain and swelling in the rhino-orbital region.The samples were recieved in normal saline and crush/imprint smears were prepared and stained with H & E,PAP and PAS stains for rapid cytological evaluation and also correlated with histopathology. Results: Total of 48 specimens from patients with suspected mucormycosis were recieved in the department of pathology, JNMCH, Aligarh over a period of six months. On cytology, out of 48 suspected caseses, 21 cases (43.8%) were found to be positive for isolated mucormycosis. 2 cases of mixed infection were also reported,1 case each of mucor with candida (2%) and mucor with aspergillous (2%). 3 cases (6.3%) were reported as suspicious for mucormycosis and 22 cases (45.8%) were diagnosed as negative. On histopathological correlation, 39 cases (81.3%) were positive for mucormycosis and 9 cases (18.7%) were negative. Among 48 cases, 43 cases (89.6%) had history of covid infection/RTPCR positive for covid infection. Diabetes was most common co-morbid condition, present in 39cases (81.3%). Conclusions: Timely diagnosis and early detection by crush/imprint smear saves the time and early treatment on the same day of admission can be started for such a lethal and angioinvasive condition.

Published Paper   E-Certificate

Saba Shakil (February-2023). A correlative study of mixed fungal infection with special emphasis on mucormycosis in covid-19 patients: An early diagnosis improves the patient outcome. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(2), c411-c419. https://ijnrd.org/papers/IJNRD2302249.pdf

Volume 8 Issue 2, February-2023

Pages : c411-c419

Paper Reg. ID: IJNRD_187795

Published Paper Id: IJNRD2302249

Downloads: 000121979

Research Area: Engineering

Country: -, -, -

Published Paper PDF: https://ijnrd.org/papers/IJNRD2302249.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2302249

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details